By Noemie Bisserbe 

PARIS--French drugmaker Sanofi SA said Wednesday it is moving to call a vote on whether to remove the entire board of Medivation Inc. after the U.S. biotech company refused to engage in takeover talks.

Sanofi said it had filed the necessary documents with the U.S. Securities and Exchange Commission and named eight candidates to replace Medivation's board of directors. The move aims to pave the way for shareholders to cast a vote through written consent.

Last month, Medivation Inc. rejected Sanofi's $9.3 billion takeover offer, claiming that the French drugmaker's proposal undervalued the cancer-treatment company.

Write to Noemie Bisserbe at noemie.bisserbe@wsj.com

 

(END) Dow Jones Newswires

May 25, 2016 08:20 ET (12:20 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Sanofi Charts.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Sanofi Charts.